Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9765858rdf:typepubmed:Citationlld:pubmed
pubmed-article:9765858lifeskim:mentionsumls-concept:C2717874lld:lifeskim
pubmed-article:9765858lifeskim:mentionsumls-concept:C0243040lld:lifeskim
pubmed-article:9765858lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:9765858lifeskim:mentionsumls-concept:C0080194lld:lifeskim
pubmed-article:9765858lifeskim:mentionsumls-concept:C0040549lld:lifeskim
pubmed-article:9765858lifeskim:mentionsumls-concept:C1511790lld:lifeskim
pubmed-article:9765858lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:9765858lifeskim:mentionsumls-concept:C0029073lld:lifeskim
pubmed-article:9765858lifeskim:mentionsumls-concept:C0033268lld:lifeskim
pubmed-article:9765858lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:9765858lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:9765858pubmed:issue9lld:pubmed
pubmed-article:9765858pubmed:dateCreated1998-10-27lld:pubmed
pubmed-article:9765858pubmed:abstractTextA total of 243 Escherichia coli strains isolated from patients with urinary tract infections (UTI) were investigated for the presence of pap, sfa and afa adhesin-encoding operons by using the polymerase chain reaction. It was found that 54%, 53% and 2% of the strains exhibited the pap, sfa and afa genotypes, respectively. Pap+ and/or sfa+ strains were more frequent in cases of acute pyelonephritis (94%) than in cases of cystitis (67%) (P < 0.001) and asymptomatic bacteriuria (57%) (P < 0.001). The pap and/or sfa operons were found in 90% of strains expressing mannose-resistant haemagglutination (MRHA) versus 37% of MRHA-negative strains (P < 0.001). The presence of pap and sfa operons was especially significant in strains belonging to MRHA types III (100%) (without P adhesins) and IVa (97%) (expressing the specific Gal-Gal binding typical of P adhesins). Both pap and sfa operons were closely associated with toxigenic E. coli producing alpha-haemolysin (Hly+) and/or the cytotoxic necrotizing factor type 1. There was an apparent correlation between the pap and sfa operons and the O serogroups of the strains. Thus, 93% of strains belonging to O1, O2, O4, O6, O7, O14, O15, O18, O22, O75 and O83 possessed pap and/or sfa operons, versus only 32% of strains belonging to other serogroups (P < 0.001). The results obtained in this study confirm the usefulness of our MRHA typing system for presumptive identification of pathogenic E. coli exhibiting different virulence factors. Thus, 85% of strains that possessed both pap and sfa adhesin-encoding operons showed MRHA types III or IVa previously associated with virulence of E. coli strains that cause UTI and bacteraemia.lld:pubmed
pubmed-article:9765858pubmed:languageenglld:pubmed
pubmed-article:9765858pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9765858pubmed:citationSubsetIMlld:pubmed
pubmed-article:9765858pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9765858pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9765858pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9765858pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9765858pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9765858pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9765858pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9765858pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9765858pubmed:statusMEDLINElld:pubmed
pubmed-article:9765858pubmed:monthDeclld:pubmed
pubmed-article:9765858pubmed:issn0923-2508lld:pubmed
pubmed-article:9765858pubmed:authorpubmed-author:JuárezAAlld:pubmed
pubmed-article:9765858pubmed:authorpubmed-author:MoraAAlld:pubmed
pubmed-article:9765858pubmed:authorpubmed-author:BlancoJJlld:pubmed
pubmed-article:9765858pubmed:authorpubmed-author:BlancoMMlld:pubmed
pubmed-article:9765858pubmed:authorpubmed-author:AlonsoM PMPlld:pubmed
pubmed-article:9765858pubmed:authorpubmed-author:BlancoJ EJElld:pubmed
pubmed-article:9765858pubmed:authorpubmed-author:BalsalobreCClld:pubmed
pubmed-article:9765858pubmed:authorpubmed-author:MuñoaFFlld:pubmed
pubmed-article:9765858pubmed:issnTypePrintlld:pubmed
pubmed-article:9765858pubmed:volume148lld:pubmed
pubmed-article:9765858pubmed:ownerNLMlld:pubmed
pubmed-article:9765858pubmed:authorsCompleteYlld:pubmed
pubmed-article:9765858pubmed:pagination745-55lld:pubmed
pubmed-article:9765858pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9765858pubmed:meshHeadingpubmed-meshheading:9765858-...lld:pubmed
pubmed-article:9765858pubmed:meshHeadingpubmed-meshheading:9765858-...lld:pubmed
pubmed-article:9765858pubmed:meshHeadingpubmed-meshheading:9765858-...lld:pubmed
pubmed-article:9765858pubmed:meshHeadingpubmed-meshheading:9765858-...lld:pubmed
pubmed-article:9765858pubmed:meshHeadingpubmed-meshheading:9765858-...lld:pubmed
pubmed-article:9765858pubmed:meshHeadingpubmed-meshheading:9765858-...lld:pubmed
pubmed-article:9765858pubmed:meshHeadingpubmed-meshheading:9765858-...lld:pubmed
pubmed-article:9765858pubmed:meshHeadingpubmed-meshheading:9765858-...lld:pubmed
pubmed-article:9765858pubmed:meshHeadingpubmed-meshheading:9765858-...lld:pubmed
pubmed-article:9765858pubmed:meshHeadingpubmed-meshheading:9765858-...lld:pubmed
pubmed-article:9765858pubmed:meshHeadingpubmed-meshheading:9765858-...lld:pubmed
pubmed-article:9765858pubmed:meshHeadingpubmed-meshheading:9765858-...lld:pubmed
pubmed-article:9765858pubmed:meshHeadingpubmed-meshheading:9765858-...lld:pubmed
pubmed-article:9765858pubmed:meshHeadingpubmed-meshheading:9765858-...lld:pubmed
pubmed-article:9765858pubmed:meshHeadingpubmed-meshheading:9765858-...lld:pubmed
pubmed-article:9765858pubmed:meshHeadingpubmed-meshheading:9765858-...lld:pubmed
pubmed-article:9765858pubmed:meshHeadingpubmed-meshheading:9765858-...lld:pubmed
pubmed-article:9765858pubmed:meshHeadingpubmed-meshheading:9765858-...lld:pubmed
pubmed-article:9765858pubmed:meshHeadingpubmed-meshheading:9765858-...lld:pubmed
pubmed-article:9765858pubmed:meshHeadingpubmed-meshheading:9765858-...lld:pubmed
pubmed-article:9765858pubmed:meshHeadingpubmed-meshheading:9765858-...lld:pubmed
pubmed-article:9765858pubmed:meshHeadingpubmed-meshheading:9765858-...lld:pubmed
pubmed-article:9765858pubmed:meshHeadingpubmed-meshheading:9765858-...lld:pubmed
pubmed-article:9765858pubmed:meshHeadingpubmed-meshheading:9765858-...lld:pubmed
pubmed-article:9765858pubmed:meshHeadingpubmed-meshheading:9765858-...lld:pubmed
pubmed-article:9765858pubmed:meshHeadingpubmed-meshheading:9765858-...lld:pubmed
pubmed-article:9765858pubmed:meshHeadingpubmed-meshheading:9765858-...lld:pubmed
pubmed-article:9765858pubmed:meshHeadingpubmed-meshheading:9765858-...lld:pubmed
pubmed-article:9765858pubmed:meshHeadingpubmed-meshheading:9765858-...lld:pubmed
pubmed-article:9765858pubmed:year1997lld:pubmed
pubmed-article:9765858pubmed:articleTitleDetection of pap, sfa and afa adhesin-encoding operons in uropathogenic Escherichia coli strains: relationship with expression of adhesins and production of toxins.lld:pubmed
pubmed-article:9765858pubmed:affiliationDepartamento de Microbiología y Parasitología, Facultad de Veterinaria, Universidad de Santiago de Compostela, Lugo, Spain.lld:pubmed
pubmed-article:9765858pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9765858pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9765858lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9765858lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9765858lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9765858lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9765858lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9765858lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9765858lld:pubmed